This site is now managed by the Commonwealth Department of Health and Aged Care. 

Australian Clinical Trials

Clinical Trial Details

Myeloma and Related Diseases Registry

Print record Print record
Trial Information

Broad Health Condition Cancer
Inflammatory and Immune System

Specific Health ConditionMyeloma
Other blood disorders
Other inflammatory or immune system disorders

Trial Focus

Recruitment Details

Recruitment status

Recruitment State

The Alfred - Prahran
Austin Health - Austin Hospital - Heidelberg
Princess Alexandra Hospital - Woolloongabba
Royal Prince Alfred Hospital - Camperdown
Sir Charles Gairdner Hospital - Nedlands
The Northern Hospital - Epping
St George Hospital - Kogarah
Peter MacCallum Cancer Centre - Melbourne
Monash Medical Centre - Clayton campus - Clayton
Cabrini Hospital - Malvern - Malvern
The Canberra Hospital - Garran
Box Hill Hospital - Box Hill
Royal Hobart Hospital - Hobart
Flinders Medical Centre - Bedford Park
Latrobe Regional Hospital - Traralgon
Concord Repatriation Hospital - Concord
Icon Cancer Care South Brisbane - South Brisbane
Icon Cancer Care Chermside - Chermside
Icon Cancer Care Southport - Southport
Icon Cancer Care Wesley - Auchenflower
Epworth Freemasons - Melbourne
Hollywood Private Hospital - Nedlands
Royal Brisbane & Womens Hospital - Herston
Lismore Base Hospital - Lismore
Barwon Health - Geelong Hospital campus - Geelong
Frankston Hospital - Frankston
St Vincent's Hospital (Melbourne) Ltd - Fitzroy
Liverpool Hospital - Liverpool
Sunshine Hospital - St Albans
Ashford Cancer Centre: Adelaide Cancer Centre - Kurralta Park
Royal North Shore Hospital - St Leonards
Bairnsdale Regional Health Service - Bairnsdale
Ballarat Health Services (Base Hospital) - Ballarat Central
Border Medical Oncology - Albury
Calvary Mater Newcastle - Waratah
St John of God Hospital, Geelong - Geelong
Central Gippsland Health Service (Sale) - Sale
Launceston General Hospital - Launceston
Nepean Hospital - Kingswood
St Vincent's Hospital (Darlinghurst) - Darlinghurst
Sunshine Coast University Hospital - Birtinya
Toowoomba Hospital - Toowoomba
Townsville University Hospital - Douglas

3004 - Prahran
3084 - Heidelberg
4102 - Woolloongabba
2050 - Camperdown
6009 - Nedlands
3076 - Epping
2217 - Kogarah
3000 - Melbourne
3168 - Clayton
3144 - Malvern
2605 - Garran
3128 - Box Hill
7000 - Hobart
5042 - Bedford Park
3844 - Traralgon
2139 - Concord
4101 - South Brisbane
4032 - Chermside
4215 - Southport
4066 - Auchenflower
3002 - Melbourne
4029 - Herston
2480 - Lismore
3220 - Geelong
3199 - Frankston
3065 - Fitzroy
2170 - Liverpool
3021 - St Albans
5037 - Kurralta Park
2065 - St Leonards
3875 - Bairnsdale
3350 - Ballarat Central
2640 - Albury
2298 - Waratah
3220 - Geelong
3850 - Sale
7250 - Launceston
2747 - Kingswood
2010 - Darlinghurst
4575 - Birtinya
4350 - Toowoomba
4814 - Douglas

Trial location outside Australia
Korea, Republic Of
Taiwan, Province Of China
Hong Kong
New Zealand

Anticipated date of last participant enrolment31/12/2040

Phase of TrialNot Applicable

Has the study received ethics approval?Further information iconApproved

Trial summary

This observational study is collecting information from patients to form the Myeloma and Related Diseases Registry (MRDR)

Who is it for?
You may be eligible for this study if you have a diagnosis of multiple myeloma, plasmacytoma, plasma cell leukaemia or monoclonal gammopathy of undetermined significance (MGUS).

Study details
Medical information including diagnostic tests, therapy and demographics will be provided by medical records. Participants can also provide information regarding their quality of life using a questionnaire.

It is hoped this registry will enable clinicians and hospitals to provide the best possible care to people with the included conditions and allow the evaluations of new therapies.


Key inclusion criteria

Patients with a new diagnosis of multiple myeloma, plasmacytoma, plasma cell leukaemia or monoclonal gammopathy of undetermined significance (MGUS). Diagnosis within 3 months prior to HREC approval at a site for myeloma, plasmacytoma, plasma cell leukaemia and within 5 years for MGUS in order to minimise retrospective data collection. 

Minimum age18 Years

GenderBoth males and females

Can Healthy volunteers participate? No

Key exclusion criteria

People who decline to participate in the registry. 
Contact details and further information

Sponsor Primary Sponsor Type: University
Primary Sponsor Name: Monash University
Primary Sponsor Address: Wellington Road Clayton, Victoria, 3800
Primary Sponsor Country: Australia

Trial website

Trial IDACTRN12618000659202

Contact person for information and recruitmentDr
Elizabeth Moore
Attn: Myeloma and Related Diseases Registry Department of Epidemiology and Preventive Medicine School of Public Health and Preventive Medicine Monash University 553 St Kilda Road, Melbourne VIC 3004
+61 3 9903 0355

Email contact Further information